Ovid Therapeutics Inc (OVID) — Cash Flow Reinvestment Rate

Latest as of March 2021: 0.00x

Ovid Therapeutics Inc (OVID) has a Cash Flow Reinvestment Rate of 0.00x as of March 2021, reinvesting $23.03K (capex $11.51K plus investments $-11.51K) from operating cash flow of $160.90 Million. Explore Ovid Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$23.03K
Capex + Investments

Operating Cash Flow

$160.90 Million
USD

Capital Expenditures

$11.51K
USD

Ovid Therapeutics Inc Cash Flow Reinvestment Rate (2021–2021)

Historical reinvestment intensity for Ovid Therapeutics Inc across 1 annual periods. Also explore OVID total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Ovid Therapeutics Inc (2021–2021)

Year-by-year capital reinvestment analysis for Ovid Therapeutics Inc. For live market cap and broader valuation context, see Ovid Therapeutics Inc market cap and net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2021 0.02x $1.82 Million $118.61 Million $184.01K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow